FDA Drug Application (202235) for IBANDRONATE SODIUM by SAGENT PHARMS

Back to FDA Applications sponsored by SAGENT PHARMS

Application Number202235
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 3MG BASE/3ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIBANDRONATE SODIUM
Active IngredientIBANDRONATE SODIUM



Back to FDA Applications sponsored by SAGENT PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.